Chronic Disease News and Research

RSS

Mild reduction in food intake slows development of autosomal-dominant polycystic kidney disease

A small reduction in food intake—less than required to cause weight loss—dramatically slowed the development of a common genetic disorder called autosomal-dominant polycystic kidney disease (ADPKD) in mice, a new study in American Journal of Physiology—Renal Physiology reports.

30 Jan 2016

Vital Strategies launched to improve global health

A new name in global health - Vital Strategies was launched today, with a mission of reducing disease and premature death and helping to deliver a world where every person has the protection of a strong public health system.

27 Jan 2016

Alignment Healthcare, HCA West Florida partner to better serve Medicare beneficiaries in West Florida

Alignment Healthcare, a company focused on improving the health of the Medicare population, announced that it has joined forces with HCA West Florida to better serve Medicare beneficiaries in three West Florida counties: Manatee, Pinellas and Sarasota.

13 Jan 2016

New article suggests that playing American football may contribute to hypertension

As National Football League playoff games are underway, a new article published in the "Hypotheses" section of the January 2016 issue of The FASEB Journal, suggests that the toll the sport takes on players' bodies extends beyond head trauma and damage to limbs and joints. The trauma and damage associated with football participation may also be linked to elevations in blood pressure through immune system activation and inflammation.

12 Jan 2016

Qualcomm Life expands global connected therapy management collaboration with Novartis

Qualcomm Incorporated today announced that its subsidiary, Qualcomm Life, Inc., and Novartis are expanding their global connected therapy management collaboration. Novartis will leverage Qualcomm Life's connectivity solutions to power its next-generation connected Breezhaler, the inhaler for its Chronic Obstructive Pulmonary Disease (COPD) portfolio.

6 Jan 2016

FDA permits Sound Pharmaceuticals to start SPI-1005 clinical trial for treatment of Meniere's Disease

Sound Pharmaceuticals is pleased to announce that it began enrolling a clinical trial to test SPI-1005 in the treatment of Meniere's Disease (MD). MD or idiopathic endolymphatic hydrops is an inner ear disease that involves episodic vertigo, sensorineural hearing loss, and tinnitus.

5 Jan 2016

Enli Health Intelligence's CareManager recognized as highest rated solution by KLAS Research

Enli Health Intelligence, a market leader in population health management technology, announced today that CareManager, its enterprise-class care coordination platform, has been recognized as the highest rated solution by KLAS Research.

4 Jan 2016

Music therapy in conjunction with standard rehabilitation benefits COPD patients

Patients with Chronic Obstructive Pulmonary Disease (COPD) and other chronic respiratory disorders who received music therapy in conjunction with standard rehabilitation saw an improvement in symptoms, psychological well-being and quality of life compared to patients receiving rehabilitation alone, according to a new study by researchers at The Louis Armstrong Center of Music and Medicine at Mount Sinai Beth Israel (MSBI).

24 Dec 2015

IASLC lauds FDA approval of alectinib for lung cancer treatment

The International Association for the Study of Lung Cancer (IASLC) is once again gratified to see the approval of a new second-generation lung cancer treatment that can help many patients in their battle against the disease.

24 Dec 2015

Patients treated at emergency departments for hypertension on the rise in US

The number and percentage of patients treated at emergency departments for hypertension are on the rise across the United States, according to a Vanderbilt University Medical Center study published recently in the American Journal of Cardiology.

22 Dec 2015

New NYUCN study examines validity of symptoms for detecting breast cancer-related lymphedema

Many are aware that hair loss is a common side effect associated with chemotherapy. However, another albeit common late side effect of cancer treatment is the abnormal swelling of one or more limbs, known as lymphedema. Lymphedema is most commonly the result of an obstruction or disruption of the lymphatic system that occurs immediately after cancer treatment or 1-5, even 20 years after.

20 Dec 2015

Study explores link between obesity and breast-cancer related lymphedema

Each year, about 1.38 million women worldwide are diagnosed with breast cancer. Advances in treatment have facilitated a 90% five-year survival rate among those treated. Given the increased rate and length of survival following breast cancer, more and more survivors are facing life-time risk of developing late effects of cancer treatment that negatively impact long-term survival. In particular, Breast cancer-related lymphedema is one of the most distressing and feared late effects.

18 Dec 2015

Standing up or walking for just five minutes could help prevent Type 2 diabetes

Women who have an inactive daily routine and are at high risk of Type 2 diabetes can help prevent the condition by regularly standing up or walking for five minutes at a time, a new study has found.

17 Dec 2015

Workplace intervention can help prevent diabetes

For people who already have high blood sugar, preventing diabetes could amount to just another day at the office.

12 Dec 2015

Fat cells produced from bone marrow may be linked to chronic diseases

Researchers at the University of Colorado Anschutz Medical Campus have found that fat cells produced by stem cells from the bone marrow may be linked to chronic illnesses like diabetes, cardiovascular disease, kidney disease and some cancers.

25 Nov 2015

IQWiG examines added benefit of tiotropium and olodaterol combination in adults with COPD

The fixed-dose combination of tiotropium and olodaterol (trade name: Spiolto Respimat) has been approved since July 2015 for maintenance treatment in adults with chronic obstructive pulmonary disease (COPD). The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this drug combination offers an added benefit over the appropriate comparator therapy.

22 Nov 2015

Chronic Disease News and Research

Mild reduction in food intake slows development of autosomal-dominant polycystic kidney disease

Vital Strategies launched to improve global health

Alignment Healthcare, HCA West Florida partner to better serve Medicare beneficiaries in West Florida

New article suggests that playing American football may contribute to hypertension

Qualcomm Life expands global connected therapy management collaboration with Novartis

FDA permits Sound Pharmaceuticals to start SPI-1005 clinical trial for treatment of Meniere's Disease

Enli Health Intelligence's CareManager recognized as highest rated solution by KLAS Research

Music therapy in conjunction with standard rehabilitation benefits COPD patients

IASLC lauds FDA approval of alectinib for lung cancer treatment

Patients treated at emergency departments for hypertension on the rise in US

New NYUCN study examines validity of symptoms for detecting breast cancer-related lymphedema

Study explores link between obesity and breast-cancer related lymphedema

Standing up or walking for just five minutes could help prevent Type 2 diabetes

Workplace intervention can help prevent diabetes

Fat cells produced from bone marrow may be linked to chronic diseases

IQWiG examines added benefit of tiotropium and olodaterol combination in adults with COPD

Survivors of gunshot violence in high-crime urban area at risk of early death

USC discoveries propose promising method to eliminate pain associated with tooth decay

Older populations in rural areas face special health care challenges

Heart of the Rockies Regional Medical Center selects Aprima EHR

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News